Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT01197560 · COMPLETED
Trial details
- NCT number
- NCT01197560
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-02
- Primary completion
- 2013-07-04
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.